PMG Family Office’s Merck MRK Stock Holding History

PMG Family Office’s Portfolio MRK Stock Details MRK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$217K	Buy	+1,677	New	+$196K	0.2%	104

Other funds holding MRK

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

PMG Family Office's MRK Position: Q2 2026 in Review

PMG Family Office opened a new position in Merck (MRK) in Q2 2026: 1,677 shares worth $217K. The stake represents 0.2% of the portfolio and ranks #104 among its holdings.

3,818 funds tracked by Wall St. Rank hold MRK as of Q2 2026.

PMG Family Office held 1,677 shares of Merck worth $217K as of Q2 2026.
Merck was a new PMG Family Office position in Q2 2026.
Merck made up 0.2% of PMG Family Office's portfolio in Q2 2026, its #104 holding.
3,818 funds tracked by Wall St. Rank held Merck as of Q2 2026.

Based on PMG Family Office's 13F filing for Q2 2026, filed 16 Jul 2026.